Our model using pre-operative PSA, clinical GS, BMI, PAP, and prostate weight was predictive of clinically significant prostate cancer and may be a tool to stratify patients with a diagnosis of prostate cancer with consideration being given to place the patient on active surveillance versus surgical treatment. This evidence concerns the gene KLK3 and prostate cancer.